Epalrestat Manufacturers India, Suppliers
Epalrestat Sustained Release Tablets 150mg Manufacturer in India
Epalrestat Tablets 150mg (EPATAJ) – Trusted Treatment for Diabetic Neuropathy
We are a leading manufacturer, exporter, and supplier of Epalrestat Sustained Release Tablets 150mg in India, delivering internationally quality-assured pharmaceutical formulations under the brand name EPATAJ. Our product is widely used in the management of diabetic neuropathy, a painful and progressive nerve disorder caused by long-term uncontrolled diabetes.
Epalrestat belongs to the class of aldose reductase inhibitors, which play a vital role in reducing nerve damage caused by sorbitol accumulation. By inhibiting this pathway, our formulation helps reduce symptoms such as burning sensation, tingling, numbness, and nerve pain, significantly improving patient comfort and quality of life.
We ensure that every batch of Epalrestat 150mg Tablets meets stringent quality benchmarks and global regulatory standards, making it suitable for regulated and semi-regulated markets across Africa, the Middle East, and Latin America (LATAM).
What is Epalrestat and How It Works?
Epalrestat is a scientifically proven aldose reductase inhibitor that helps control diabetic complications affecting peripheral nerves.
In diabetic conditions, excess glucose is converted into sorbitol through the aldose reductase pathway. The accumulation of sorbitol in nerve tissues leads to oxidative stress and nerve damage. Epalrestat works by:
- Inhibiting the aldose reductase enzyme
- Reducing sorbitol accumulation in nerve cells
- Preventing further nerve degeneration
- Improving nerve conductivity and function
This mechanism makes Epalrestat a preferred therapeutic option in diabetic peripheral neuropathy management.
Therapeutic Uses of Epalrestat 150mg Tablets
Our Epalrestat Sustained Release Tablets 150mg are recommended for:
- Diabetic neuropathy (nerve pain due to diabetes)
- Peripheral nerve damage
- Tingling and burning sensations in limbs
- Numbness in hands and feet
- Long-term diabetic complications affecting nerves
By improving nerve metabolism, Epalrestat helps patients regain mobility comfort and reduce pain intensity over time.
Sustained Release Technology – Advanced Drug Delivery
We manufacture Epalrestat 150mg Sustained Release Tablets using advanced pharmaceutical technology that ensures:
- Controlled and extended drug release
- Improved patient compliance with once-daily dosing
- Stable therapeutic plasma concentration
- Reduced gastrointestinal side effects
- Enhanced clinical effectiveness
This formulation ensures consistent relief from neuropathic symptoms throughout the day.
Taj Pharma – Leading Epalrestat Manufacturer in India
We are a globally recognized pharmaceutical company headquartered in Vapi, Gujarat, India, specializing in high-quality finished dosage formulations.
As a trusted Epalrestat Tablets manufacturer and exporter, we focus on:
- WHO-GMP certified manufacturing facilities
- International standard quality control systems
- Research-driven formulation development
- Bulk production capacity for global supply
- Regulatory-compliant documentation for exports
Our manufacturing expertise ensures that every tablet of EPATAJ Epalrestat 150mg delivers consistent therapeutic results.
Global Export Market – Africa, Middle East & LATAM
We are a strong global supplier of Epalrestat Sustained Release Tablets 150mg, catering to diverse pharmaceutical markets including:
- Africa (Nigeria, Kenya, Ghana, South Africa, etc.)
- Middle East (UAE, Saudi Arabia, Iraq, Yemen, etc.)
- Latin America (Brazil, Mexico, Peru, Colombia, etc.)
Our export services include:
- Fast international shipping
- Customized packaging solutions
- Private labeling & contract manufacturing
- Regulatory dossier support (CTD/ACTD formats)
We ensure timely delivery and consistent supply for distributors, wholesalers, and healthcare institutions worldwide.
Quality Assurance & Manufacturing Excellence
We follow strict pharmaceutical quality protocols at every stage of production:
- Raw material testing and validation
- In-process quality control checks
- Finished product stability testing
- Microbiological and chemical analysis
- Compliance with WHO-GMP standards
Our Epalrestat Tablets 150mg are manufactured in a controlled environment ensuring purity, safety, and efficacy.
Dosage & Administration Guidelines
Epalrestat Sustained Release Tablets are generally recommended as:
- Once daily dosage (as prescribed by a physician)
- Taken after meals for better absorption
- Swallowed whole with water (not crushed or chewed)
The dosage may vary depending on patient condition and medical evaluation.
Safety Information & Side Effects
Epalrestat is generally well tolerated. However, some patients may experience mild and temporary side effects such as:
- Nausea
- Vomiting
- Mild abdominal discomfort
- Abnormal liver function (rare cases)
Most side effects are temporary and resolve as the body adjusts to the medication. Regular monitoring may be advised in long-term therapy.
Why Choose Our Epalrestat 150mg Tablets?
We stand among the most trusted pharmaceutical manufacturers in India due to:
- High-quality formulation standards
- Cost-effective global pricing
- Bulk manufacturing capability
- Strong export network
- Ethical and transparent business practices
- Consistent product availability
Our brand EPATAJ is recognized for reliability, safety, and clinical effectiveness in diabetic neuropathy management.
PCD Pharma Franchise & Business Opportunities
We also offer lucrative PCD Pharma Franchise opportunities for Epalrestat 150mg Tablets across India.
Benefits include:
- Monopoly-based distribution rights
- High profit margins
- Marketing and promotional support
- Strong brand recognition
- Continuous product supply
This makes it an ideal opportunity for pharma distributors and entrepreneurs looking to enter the diabetic care segment.
Packaging & Supply Strength
We provide flexible packaging options to meet diverse market needs:
- Alu-Alu blister packs
- Strip packaging
- Bulk export cartons
- Customized private labeling
Each packaging format ensures product stability and long shelf life under international storage conditions.
Commitment to Global Healthcare Standards
We are committed to improving diabetic care worldwide through advanced pharmaceutical innovation. Our Epalrestat Sustained Release Tablets 150mg reflect our dedication to:
- Patient safety
- Clinical effectiveness
- Global accessibility
- Affordable healthcare solutions
With strong regulatory compliance and modern manufacturing infrastructure, we continue to expand our presence across international markets.
We are a trusted Epalrestat 150mg manufacturer, exporter, and supplier in India, delivering world-class pharmaceutical solutions for diabetic neuropathy management. Our sustained release formulation ensures long-lasting relief and improved patient outcomes.
With a strong global distribution network and WHO-GMP certified manufacturing facilities, we remain committed to providing high-quality medicines under the brand EPATAJ across Africa, Middle East, and LATAM markets.
